Both in Pharmaceuticals
Xencor vs NewAmsterdam Pharma Company N.V
Over the past year XNCR returned +155.7% and NAMS returned −42.7%; their daily moves had a correlation of 0.36.
XNCR +155.7% NAMS −42.7%Growth of $1, one year, split-adjusted
| Metric | XNCR | NAMS |
|---|---|---|
| Price | $35.03 | $20.93 |
| Market cap | $2.60B | $2.50B |
| Today | +14.33% | +5.18% |
| 1 month | +43.8% | −6.0% |
| 6 months | +169.3% | −32.5% |
| Year to date | +128.8% | −40.3% |
| 1 year | +151.3% | −43.4% |
| Revenue growth (YoY) | +17.5% | −80.7% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −42.4% | −1732.9% |
| P/E (TTM) | — | — |
| Price / sales | 24.8× | 351.3× |
| Net cash | $351.6M | $633.9M |
| Dividend yield | — | — |
| Volatility (60d) | 67.2% | 52.4% |
| Short % of float | 17.0% | 16.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).